Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease.
about
Inflammation and intracellular metabolism: new targets in OAEmerging regulators of the inflammatory process in osteoarthritisOsteoarthritis year 2011 in review: biologyNutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritisThe age-related changes in cartilage and osteoarthritisThe beneficial effects of exercise on cartilage are lost in mice with reduced levels of ECSOD in tissuesProcainamide Inhibits DNA Methylation and Alleviates Multiple Organ Dysfunction in Rats with Endotoxic ShockIncreased DNA Methylation and Reduced Expression of Transcription Factors in Human Osteoarthritis Cartilage.Bach1 deficiency reduces severity of osteoarthritis through upregulation of heme oxygenase-1Immunopathogenesis of osteoarthritisIdentification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosisProteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells.Mitochondrial DNA (mtDNA) haplogroups and serum levels of anti-oxidant enzymes in patients with osteoarthritis.Superoxide dismutase 1 loss disturbs intracellular redox signaling, resulting in global age-related pathological changes.Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylationFoxO transcription factors support oxidative stress resistance in human chondrocytesPeroxisome proliferator-activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP-activated protein kinase.Mitochondrial respiration and redox coupling in articular chondrocytesEupatilin Exerts Antinociceptive and Chondroprotective Properties in a Rat Model of Osteoarthritis by Downregulating Oxidative Damage and Catabolic Activity in ChondrocytesMechanical overloading causes mitochondrial superoxide and SOD2 imbalance in chondrocytes resulting in cartilage degeneration.Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism.Effects of aging on articular cartilage homeostasis.Synovium and the innate inflammatory network in osteoarthritis progression.Delphinidin inhibits IL-1β-induced activation of NF-κB by modulating the phosphorylation of IRAK-1(Ser376) in human articular chondrocytes.Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats.Cytosolic caspases mediate mislocalised SOD2 depletion in an in vitro model of chronic prion infection.Ageing and the pathogenesis of osteoarthritis.The future of osteoarthritis therapeutics: targeted pharmacological therapyDysregulated FOXO transcription factors in articular cartilage in aging and osteoarthritis.Ursodeoxycholic Acid ameliorates pain severity and cartilage degeneration in monosodium iodoacetate-induced osteoarthritis in rats.Impact of inflammation on the osteoarthritic niche: implications for regenerative medicine.Epigenetics in osteoarthritis and its implication for future therapeutics.Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage.Epigenetics of osteoarticular diseases: recent developments.Oxidative stress and chronic inflammation in osteoarthritis: can NRF2 counteract these partners in crime?ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity.Global and targeted metabolomics of synovial fluid discovers special osteoarthritis metabolites.Computational modelling folate metabolism and DNA methylation: implications for understanding health and ageing.Quantitative Mass Spectrometry To Study Inflammatory Cartilage Degradation and Resulting Interactions with the Complement System.Aging and osteoarthritis.
P2860
Q26777620-EBEABED5-0FED-4889-807A-67CCDC528F2DQ26829840-051C49D4-C0A1-4FFB-87F0-CD5B228753BDQ26853546-CEE56792-4ACA-4774-9CDD-D392952E3F21Q26860861-894F3856-514E-4229-83D7-A3CA4AD31AA8Q26863325-D7543F36-E560-4407-B21D-A466BA4118CAQ28390898-D7995EA0-B967-4C7E-B8B8-AA00EE238DCCQ28554338-62530510-564E-4AFA-BEBF-2D25DBC5ABADQ30100430-97E60654-051D-4B7F-BED0-0E8ED16A1542Q30401142-EE5C38DB-16A7-4683-A461-ABC345E160D3Q33587966-B06EBEDA-5F31-4FF5-911B-E8DAD2226180Q33899085-FE7FE842-C259-40DB-AFF5-22EC68042FBAQ34050763-4902021F-CB5F-4CCB-8DF1-74EDC19AD9A7Q34080402-F434E8AA-D22A-41A8-A3A1-62437E9378FBQ34222194-E19EB6B1-071A-4136-B9DF-333722E6171AQ34416053-AD40F8B8-1CAC-410F-ADCD-809CE1EAF59AQ34626746-A4CF132E-6255-4E85-B07F-5B70BB343883Q35128583-8137E6D2-C014-4725-9AAE-5C5D515B0BE0Q35257654-669F2ABC-E431-4ACA-A565-DF3DEAD7ECB4Q35665907-FDA2AB0A-1EB0-4616-8343-EC7FD77A1C1AQ35778885-56E8348E-4982-45C4-AC60-B880DE0C7D2EQ35825296-F6A205E7-ABE7-4235-8363-5CBEBFB24A53Q36024475-4F34E598-6025-4345-8E1A-3B78B088E24DQ36813665-7C94E202-4E9F-423D-9AAE-605CF41F2C2BQ36836151-5FCE9334-D987-45CB-A68E-0F9647451E0BQ36948589-DE820638-B87D-4370-9308-3F50E62164EAQ36981826-29F200B8-81A3-4367-96AA-10C3D7FCD5CBQ37078239-496B5851-EA08-4DBF-9E93-ED8AB1C038CDQ37213622-44376026-D4DF-40AE-9073-B15F14CE48E2Q37600074-0E3DD3A0-5B58-44C6-8C0E-914B24870787Q37617217-5B9BA475-4366-47A7-98A2-C246E8F6A35DQ38027919-3D766C9D-7259-41AB-B0F3-402385806A55Q38081554-00C8DE28-D502-4713-AB8D-AA56BBA7C199Q38319402-E048CFFF-4E8F-4F2D-8F47-FA9A55078624Q38392120-1EB9B51E-2F24-46F0-9A79-541EBDEA2311Q38702248-1987AC03-5E05-4ACC-A310-0D11C0172A9AQ38764119-2C99EBAE-7B7A-496C-A11D-1D74FC51686FQ38821499-BD49BFB2-5034-494C-B178-57FD1DA28E5FQ39051031-7E5ABFB1-A54D-4C79-85C8-1E2F5C5BEE97Q40539859-E7C3E6DE-DA9A-4BB9-A0B5-F782D329F83DQ42011299-B3398FB3-B16F-4F08-9A2B-029A59973764
P2860
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease.
@en
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease.
@nl
type
label
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease.
@en
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease.
@nl
prefLabel
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease.
@en
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease.
@nl
P2093
P2860
P356
P1476
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease.
@en
P2093
Christos Gabrielides
David A Young
Gillian A Wallis
Ian M Clark
Jenny L Scott
Raymond P Boot-Handford
Robert W Taylor
Rose K Davidson
Tom B L Kirkwood
Tracey E Swingler
P2860
P304
P356
10.1136/ARD.2009.119966
P407
P577
2010-05-28T00:00:00Z